ProCE Banner Activity

An Expert’s Guide to ESMO 2022: A Preview of the Top Abstracts

Conference Coverage
Clinical Thought

Experts highlight key studies being presented at the upcoming 2022 ESMO Congress. The CCO ESMO Congress coverage program will have the information you need to understand and integrate the latest oncology data into your practice.

Released: September 08, 2022

Expiration: September 07, 2023

Share

Faculty

Nicoletta Colombo

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Robert Motzer

Robert Motzer, MD

Attending Physician
Memorial Sloan-Kettering Cancer Center
New York, New York

David Planchard

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Rachna Shroff

Rachna Shroff, MD, MS

Professor of Medicine
Chief, Section of GI Medical Oncology
Director, UACC Clinical Trials Office
The University of Arizona Cancer Center
Tucson, Arizona

Sara M. Tolaney

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bristol Myers Squibb

Exelixis, Inc.

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Nicoletta Colombo, MD, PhD: consultant/advisor/speaker: AstraZeneca, Clovis Oncology, Eisai, GlaxoSmithKline, Immunogen, Merck Sharp and Dohme, Mersana, Novartis, Nuvation Bio, Onxerna, Pfizer, Pieris, Roche; researcher: AstraZeneca, Roche.

Robert Motzer, MD

Attending Physician
Memorial Sloan-Kettering Cancer Center
New York, New York

Robert Motzer, MD: consultant/advisor/speaker: AstraZeneca, Aveo, Eisai, EMD Serono, Genentech/Roche, Merck, Pfizer

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

David Planchard, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Janssen, Novartis, Pfizer, Roche.

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Elizabeth Plimack, MD, MS: consultant/advisor/speaker: Astellas, AstraZeneca, Aveo, Bristol-Myers Squibb, Calithera, EMD Serono, Exelixis, IMV, Infinity Pharma, Janssen, MEI, Merck, Natera, Pfizer, Regeneron, Seagen; researcher: Astellas, Bristol-Myers Squibb, Genentech, Merck.

Rachna Shroff, MD, MS

Professor of Medicine
Chief, Section of GI Medical Oncology
Director, UACC Clinical Trials Office
The University of Arizona Cancer Center
Tucson, Arizona

Rachna Shroff, MD: consultant/advisor/speaker: AstraZeneca, Bayer, Boehringer Ingelheim, CAMI, Clovis, Genentech, IMV Inc., Incyte, Nucana, Pieris, QED, Rafael, Seagen, Servier, Taiho, Zymeworks; researcher: Bristol-Myers Squibb, Exelixis, Loxo, Merck, Novocure.

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Sara Tolaney, MD, MPH: consultant/advisor/speaker: 4D Pharma, ARC Therapeutics, AstraZeneca, Athenex, BeyondSpring Pharmaceuticals, Blueprint Medicines, Bristol-Myers Squibb, Certara, Chugai Pharmaceutical, CytomX Therapeutics, Daiichi Sankyo, Eisai, Ellipses Pharma, Genentech/Roche, Gilead, Infinity Therapeutics, Lilly, Merck, Mersana, Myovant, Novartis, Odonate Therapeutics, OncoSec Medical Inc., OncXerna, Pfizer, Reveal Genomics, Sanofi, Seagen, Umoja Biopharma, Zentalis, Zetagen, Zymeworks; researcher: AstraZeneca, Bristol-Myers Squibb, Cyclacel, Eisai, Exelixis, Genentech/Roche, Gilead, Lilly, Merck, NanoString Technologies, Nektar, Novartis, Pfizer, Sanofi, Seagen.